|
13
|
|
B-cell depletion improves therapeutic index of combination checkpoint blockade in patients with advanced melanoma.
(jci.org)
|
Dhodapkar KM
…
Dhodapkar MV
Journal of Clinical Investigation
2026-08-25
|
#immunotherapy
#melanoma
#autoimmunity
#checkpoint
#toxicity
|
|
8
|
|
Convergent roles of GDF-15 in mechanotransduction, vascular disorganization, and immune suppression in melanoma.
(pnas.org)
|
Chen YC
…
Robertson GP
PNAS
2026-08-24
|
#melanoma
#mechanotransduction
#immunosuppression
#microenvironment
#angiogenesis
|
|
2
|
|
Melanoma to rhabdomyosarcoma plasticity in the setting of immunotherapy.
(linkinghub.elsevier.com)
|
Knight AD
…
Mehta A
Cell Med
2026-08-20
|
#immunotherapy
#melanoma
#amr
#sequencing
#plasticity
|
|
1
|
|
UV irradiation drives lineage-specific MITF-mediated transcription of PD-L1 to confer immune tolerance to UV-mutated melanocytes.
(linkinghub.elsevier.com)
|
Lo JA
…
Fisher DE
Immunity
2026-08-13
|
#melanoma
#immunotolerance
#transcription
#uv-exposure
#immunotherapy
|
|
0
|
|
Melanoma exosomal hsa-miR-221-5p suppresses keratinocyte LL-37 to promote tumor progression.
(linkinghub.elsevier.com)
|
Sun Q
…
Niyonsaba F
Cell Reports
2026-08-12
|
#melanoma
#microrna
#exosome
#immunity
#keratinocytes
|
|
0
|
|
The mitochondria enzyme OGDH defends against disulfidptosis by licensing METTL3-regulated NRF2 translation.
(nature.com)
|
Chen XY
…
Chen HZ
Nature Cell Biology
2026-08-07
|
#melanoma
#disulfidptosis
#apoptosis
#metabolism
#oxidative stress
|
|
0
|
|
Transposable elements and homotypic niches drive immune dynamics and resistance in melanoma epigenetic-based immunotherapy.
(science.org)
|
Ciervo E
…
Ceccarelli M
Science Advances
2026-08-07
|
#immunotherapy
#melanoma
#amr
#transcriptomics
#epigenetics
|
|
0
|
|
Chronic interferon signaling at baseline is associated with acquired resistance to immunotherapy in metastatic melanoma.
(linkinghub.elsevier.com)
|
Egan D
…
Turajlic S
Cell Reports Medicine
2026-08-07
|
#immunotherapy
#melanoma
#transcriptomics
#immunoresistance
#interferon
|
|
0
|
|
Immunologic determinants of infusion products and the tumor microenvironment govern response to TIL therapy in advanced melanoma.
(linkinghub.elsevier.com)
|
Karapetyan L
…
Pilon-Thomas S
Cell Med
2026-07-29
|
#immunotherapy
#melanoma
#transcriptomics
#immunophenotyping
#checkpoint-inhibitors
|
|
0
|
|
Immunotherapy of malignant melanoma using T cell-activating microbeads.
(academic.oup.com)
|
Hassan NT
…
Beyersdorf N
Journal of Immunology
2026-08-04
|
#immunotherapy
#melanoma
#t-cells
#checkpoint-inhibitors
#cytotoxicity
|